 |
doxorubicin |
|---|---|
| Trade Name | |
| Orphan Indication | Cutaneous T-cell lymphoma |
| USA Market Approval | USA |
| USA Designation Date | 2015-04-06 00:00:00 |
| Sponsor | Louis D. Falo, Jr.;University of Pittsburgh, Dep. of Dermatology, 3500 Fifth Avenue;Pittsburgh, Pennsylvania, 15213 |
Related Access Program